<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02840656</url>
  </required_header>
  <id_info>
    <org_study_id>P140907</org_study_id>
    <nct_id>NCT02840656</nct_id>
  </id_info>
  <brief_title>Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization</brief_title>
  <acronym>OroColi-HS</acronym>
  <official_title>Comparative Microbial Epidemiology and Chlorhexidine Suscebtibily of Oropharyngeal and Intestinal Colonization of Healthy Adults Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective observational study we aim to determine the prevalence of oropharyngeal
      and rectal Gram-negative bacilli colonization in healthy subjects, and their susceptibility
      to chlorehexidine. We plan to recruit 100 healthy volunteers secondary endpoints are to
      determine the phylogentic characteristics of E. coli isolates; to compare the phylogentic
      characteristics of oropharyngeal and rectal of predominant GNB colonization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this prospective observational study we aim to determine the prevalence of oropharyngeal
      and rectal Gram-negative bacilli colonization in 100 healthy subjects, and their
      susceptibility to chlorehexidine. Each participant will undego a oropharyngeal swab
      collection and a rectal swab at day 0. The Gram-negative bacilli colonization will be
      identified, E. coli isolates will be studied in terms of phylogeny; gram-negative isolates
      will be studied in terms of antimicrobial and chlorhexidine susceptibility. The primary
      objective is to determine the prevalence of oropharyngeal Gram-negative bacilli colonization.
      The secondary objectives are to determine the chlorhexidine and antimicrobial susceptibility
      of such colonization; to determine the phylogentic characteristics of oropharyngeal and
      rectal predominant E. coli isolates; to compare the phylogentic characteristics of
      oropharyngeal and rectal E. coli isolates.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of patients with an oropharyngeal gram-negative colonization</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of the a GNB oropharyngeal colonization</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparision of the predominant fecal flora with GNB oropharyngeal colonization</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>characterization of antimicrobial and chlorhexidine susceptibility of Gram negative bacteria from oropharyngeal colonization</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>phylogenetic and virulence factor content of E. coli oropharyngeal and rectal colonization</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Oropharyngeal Gram-negative Bacilli Colonization</condition>
  <arm_group>
    <arm_group_label>healthy adult subject</arm_group_label>
    <description>oropharyngeal and rectal swabbing to collect Gram-negative bacilli</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oropharyngeal swabbing</intervention_name>
    <description>microbiological sampling will be performed on buccal mucosa with standard swab. only one sample will be done</description>
    <arm_group_label>healthy adult subject</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>rectal swabbing</intervention_name>
    <description>same process as oropharyngeal swabbing will be used to collect rectal microbiological sample</description>
    <arm_group_label>healthy adult subject</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        healthy volonteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 yo

          -  personal history of neck or face irradiation

          -  no history of gastrointestinal disease

          -  no symptoms of immunosuppression

          -  no antibiotic therapy in the previous month

          -  no hospitalization in the 3 months preceding inclusion

          -  medical exmination prior to inclusion

        Exclusion Criteria:

          -  affiliated to the social security

          -  The refusal of a patient to participate in a study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan MESSIKA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Louis Mourier - Assistance Publique Hopitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jonathan MESSIKA, MD</last_name>
    <phone>+331 47 60 63 29</phone>
    <email>jonathan.messika@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Damien RICARD, MD, Ph D</last_name>
    <phone>+331 47 60 61 91</phone>
    <email>jean-damien.ricard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AP-HP, Louis Mourier Hospital</name>
      <address>
        <city>Colombes</city>
        <state>Ile De France</state>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jonathan MESSIKA, MD</last_name>
      <email>jonathan.messika@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2016</study_first_posted>
  <last_update_submitted>January 18, 2018</last_update_submitted>
  <last_update_submitted_qc>January 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

